Comparative kinetics of two orally administered fluoroquinolones in dog : Enrofloxacin versus Marbofloxacin

Revue de Medecine Veterinaire

Volumn 147, Issue 10, 1996, Pages 703-716

  Cester, C C ^a   Schneider, M ^b   Toutain, P L ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Vetoquinol Research Centre   (France)

Author keywords

Ciprofloxacin; Dogs; Enrofloxacin; HPLC; Marbofloxacin; Microbiological assay; Pharmacokinetics

Indexed keywords

EID: 0030506356     PISSN: 00351555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. - BARSANTI (J.A.) and JOHNSON (C.A.) : Genitourinary infections. In : Infectious Diseases of the Dog and Cat. C.E. GREENE (ed.), W.B. Saunders Company, Philadelphia. 1990, p 157-183.
2. - BROWN (S.A.) : Fluoroquinolones in animal health. J. Vet. Pharmacol. Therap., 1996, 19, 1-14.
3. - CESTER (C.C.) and TOUTAIN (P.L.) : Enrofloxacin as a prodrug of ciprofloxacin in dog : an HPLC versus microbiological assay pharmacokinetic study. (Unpublished results).
4. - DUDLEY (M.N.) : Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones. Am. J. Med., 1991, 91 (Suppl. 6A), 45-50.
5. - FUJIMAKI (K.), NOUMI (T.), SAIKAWA (I.), INOUE (M.) and MITSUHASHI (S.) : In vitro and in vivo antibacterial activities of T3262, a new fluoroquinolone. Antimicrob. Agents Chemother., 1988, 32, 827-833.
6. - GIBALDI (M.) and PERRIEI (D.) : One compartment model. In : Pharmacokinetics. J. SWARBRICK (ed.), 2nd edn. M. Dekker, New York, 1982, p 1-43.
7. - GRIZZLE (J.E.) : The two-period change-over design and its use in clinical trials. Biometrics, 1965, 21, 467-480.
8. - HYATT (J.M.), MACKINNON (P.S.), ZIMMER (G.S.) and SCHENTAG (J.J.) : The importance of pharmacokinetic/ pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clin. Pharmacokinet., 1995, 28, 143-160.
9. - IRKE (P.J.) : Integumentary infections. In : Infectious Diseases of the Dog and Cat. C.E. GREENE (ed.), W.B. Saunders Company, Philadelphia, 1990, p 73-83.
10. - KÄÄRTINEN (L.), SALONEN (M,), ÄLLI (L.) and PYÖRÄLÄ (S.) : Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. J. Vet. Pharmacol. Therap., 1995, 18, 357-362.
11. - KECK (G.) and BORNE (P.M.) : Nouvelles conceptions en antibiothérapie et leurs applications pratiques en médecine vétérinaire. Revue Méd. Vét., 1995, 146, 309-320.
12. - KÜNG (K.), RIOND (J.L.), WOLFRAM (S.) and WANNER (M.) : Comparison of an HPLC and bioassay method to determine antimicrobial concentrations after intravenous and oral administration of enrofloxacin in four dogs. Res. Vet. Sci., 1993a, 54, 247-248.
13. - KÜNG (K.), RIOND (J.L.) and WANNER (M.) : Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J. Vet. Pharmacol. Therap., 1993b, 16, 462-468.
14. - KÜNG (K.) and WANNER (M.) : Pharmacokinetic von Baytril® (Enrofloxacin) beim Hund. Schweiz. Arch. Tierheilk., 1994, 136, 329-334.
15. - LAM (F.C.), HUNG (C.T.) and PERRIER (D.G.) : Estimation of variance for harmonic mean half-time. J. Pharm. Sci., 1985, 74, 229-231.
16. - LEES (G.E.) and FORRESTER (S.D.) : Update : bacterial urinary tract infections. In : Current Veterinary Therapy, vol. XI, Small Animal Practice. W.B. Saunders, Philadelphia, 1992, p 909-914.
17. - LODE (H.), HÖFFKEN (G.), BORNER (K.) and KOEPPE (P.) : Unique aspects of quinolone pharmacokinetics. Clin. Pharmacokinet., 1989, 16 (Suppl. 1), 1-4.
18. - MEINEN (J.B.), MACCLURE (J.T.) and ROSIN (E.) : Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. Am. J. Vet. Res., 1995, 56, 1219-1224.
19. - MEVIUS (D. J.), BREUKINK (H. J.) and VAN MIERT (A.S.J P.A.M.) : In vitro activity of flumequine in comparison with several other antimicrobial agents against five isolated pathogens isolated in calves in the Netherlands. Vet. Quaterly, 1990, 12, 212-220.
20. - NEU (H.C.), FANC (W.), GU (J-W.) and CHIN (N-X.) : In vitro activity of OPC-17116. Antimicrob. Agents Chemother., 1992, 36, 1310- 1315.
21. - NEUMAN (M.) : Comparative pharmacokinetic parameters of new systemic fluoroquinolones. Int. J. Clin. Pharm. Res., 1987, 7, 173- 179.
22. - PETRACCA (K.) : Die pharmakokinetic des Gyrasehemmers Ro 09- 1168 bei der Sau : Einfluss von Trächtigkeit und Laktation. Vet. Med. Thesis, Zürich, 1992.
23. - SCHNEIDER (M.), THOMAS (V.), BOISRAME (B.) and DELEFORGE (J.) : Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. J. vet. Pharmacol. Therap., 1996, 19, 56-61.
24. - SHAH (V. P.), MIDHA (K. K.), DIGHE (S.), McGILVERAY (I. J.), SKELLY (J. P.), YACOBI, (A.), LAYLOFF (T.), VISWANATHAN (C. T.), COOK (C. E.), McDOWALL (R. D.), PITTMAN (K. A.) and SPECTOR (S.) : Analytical methods validation : bioavailability, bioequivalence, and pharmacokinetic studies. J. Pharm. Sci. 1992, 81, 309-312.
25. - SHEER (M.) : Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Vet. Med. Rev., 1987a, 2, 104-118.
26. - SHEER (M.) : Studies on the antibacterial activity of Baytril. Vet. Med. Rev., 1987b, 2, 90-99.
27. - SÖRGEL (F.), JAEHDE (U.), NABER (K.) and STEPHAN (U.) : Pharmacokinetic disposition of quinolones in human body fluids and tissues. Clin. Pharmacokinet., 1989, 16 (Suppl. 1), 5-24.
28. - SPRENG (M.), DELEFORGE (J.), BOISRAME (B.) and DRUGEON (H.) : Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. J. Vet. Pharmacol. Therap., 1995, 18, 284-289.
29. - VANCE-BRYAN (K.), GUAY (D.R.P.) and ROTSCHAFER (J.C.) : Clinical pharmacokinetics of ciprofloxacin. Clin. Pharmacokinet., 1990, 19, 434-461.
30. - VANCUTSEM (P.M.), BABISH (J.G.) and SCHWARK (W.S.) : The fluoroquinolone antimicrobials : structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet., 1990, 80, 173-186.
31. - WALKER (R.D.), STEIN (G.E.), HAUPTMAN (J.G.) and MACDONALD (K.H.) : Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am. J. Vet. Res., 1992, 53, 2315-2319.
32. - WATTS (J.L.), SALMON (S.A.), YANCEY (J.R.), NICKERSON (S.C.), WEARVER (L.J.), HOLMBERG (C.), PANKEY (J.W.) and FOX (L.K.) : Antimicrobial susceptibility of microrganisms isolated from the mammary glands of dairy heifers. J. Dairy Sci., 1995, 78, 1637- 1648.
33. - WISE (R.), ANDREWS (J.M.) and BRENWALD (N.) : The in vitro activity of Bay y 3118, a new fluoroquinolone. J. Antimicrob. Chemother., 1993, 31, 73-80.
34. - YAMAOKA (K.), NAKAGAWA (T.) and UNO (T.) : Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm., 1978, 6, 165-175.
35. - YAMAOKA (K.), TANIGAWARA (T.), NAKAGAWA (T.) and UNO (T.) : A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobiodyn., 1981, 4, 879-885.
36. - ZEILER (H.J.), PETERSEN (U.), GAU (W.) and PLOSCHKE (H.J.) : Antibacterial activity of the metabolites of ciprofoxacin and its significance in the bioassay. Arzneim.-Forsch./Drug Res., 1987, 37, 131-134.